Bone disease in patients with kidney disease: A tricky interplay.
Managing bone disease in patients with kidney disease involves frequent lab testing and careful evaluation of therapeutic options. This review provides guidance.
The Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA.
Heather
H
Nyman
The Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. Email: karly.pippitt@hsc.utah.edu.
Karly
K
Pippitt
The Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA.
Alisyn
A
Hansen
The Department of Pharmacotherapy, University of Utah College of Pharmacy and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Karen
K
Gunning
D001847:Bone Diseases / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D005194:Family Practice / Q000592:standards*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D014481:United States / Q000453:epidemiology